/PRNewswire/ Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("HRGN" or the "Company"), a clinical-stage biotechnology company developing the.
Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HOLLISTON - Biostage, Inc. , a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth.
Biostage to Host Investor Call streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HOLLISTON, Mass., June 13, 2023 /PRNewswire/ Biostage, Inc. , a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases,. | June 13, 2023